Search the MBS

Standard Search

Advanced Search Search Tips

Enter keywords or item numbers below
Search Options

Results 1 to 1 of 1 matches

Category 5 - DIAGNOSTIC IMAGING SERVICES

61369

61369 - Additional Information

Item Start Date:
01-Jul-2018
Description Updated:
01-May-2020
Schedule Fee Updated:
01-Nov-2006

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Indium-labelled octreotide study (including single photon emission tomography when undertaken), if:
(a) a gastro-entero-pancreatic endocrine tumour is suspected on the basis of biochemical evidence with negative or equivocal conventional imaging; or
(b) both:
(i) a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified on the basis of conventional techniques; and
(ii) the study is to exclude additional disease sites (R)



Fee: $2,015.75 Benefit: 75% = $1,511.85 85% = $1,922.55

Results 1 to 1 of 1 matches


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change